Table 3.
Outcome title | Number of studies | Number of participants | Statistical method | Effect size | P-value |
---|---|---|---|---|---|
Pruritus | 4 | 59 | Odds ratio (M–H, fixed, 95% CI) | 0.39 (0.09–1.78) | 0.23 |
Adverse events | 5 | 68 | Odds ratio (M–H, fixed, 95% CI) | 0.21 (0.03–1.25) | 0.09 |
Alkaline phosphatase | 6 | 84 | Mean difference (IV, fixed, 95% CI) | −90.44 (−119.95 to −60.92) | <0.00001 |
Gamma-glutamyl transferase | 4 | 48 | Mean difference (IV, fixed, 95% CI) | −61.58 (−122.80 to −0.35) | 0.05 |
Immunoglobulin M | 5 | 62 | Mean difference (IV, fixed, 95% CI) | −38.45 (−64.38 to −12.51) | 0.004 |
Alanine aminotransferase | 4 | 61 | Mean difference (IV, fixed, 95% CI) | −3.31 (−14.60 to 7.97) | 0.56 |
Total bilirubin | 4 | 61 | Mean difference (IV, fixed, 95% CI) | −0.05 (−0.21 to 0.12) | 0.58 |
Triglycerides | 4 | 61 | Mean difference (IV, fixed, 95% CI) | −0.41 (−0.82 to −0.01) | 0.05 |
Abbreviations: M–H, Mantel–Haenszel; CI, confidence interval; IV, inverse-variance.